This inventor holds 1 USPTO granted patent. Top assignee: Egyt Gyogyszervegyeszeti Gyar. Active years: 1987.
Company Filing History:
Years Active: 1987
Title: Ilona Bor: Innovator in Pharmaceutical Technology
Introduction
Ilona Bor is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of sustained release formulations. Her innovative approach has the potential to enhance the effectiveness of medications.
Latest Patents
Ilona Bor holds a patent for "Sustained release pharmaceutical tablets and process for the preparation." This invention provides a method for preparing sustained release tablets that include a hydrophilic polymer matrix, which constitutes at least 10% by weight of the composition. The matrix consists of a 5:1-1:5 weight to weight ratio mixture of a VP-VA copolymer and an acrylic acid homopolymer, cross-linked with polyallyl saccharose. The manufacturing method can be accomplished in two ways: by creating granulate containing the active ingredient or by supplementing the matrix granulate with the active ingredient. This latter method allows for the separation of large-scale manufacturing of pharmacons and a generally applicable retardizing system, which can be modified according to the properties of the active ingredients.
Career Highlights
Ilona Bor is associated with Egyt Gyogyszervegyeszeti Gyar, where she applies her expertise in pharmaceutical development. Her work focuses on creating innovative solutions that improve drug delivery systems. With her patent, she has positioned herself as a key player in the pharmaceutical industry.
Collaborations
Ilona collaborates with notable colleagues, including Pal Fekete and Zoltan Toth. Their combined efforts contribute to advancements in pharmaceutical research and development.
Conclusion
Ilona Bor's contributions to the field of pharmaceutical technology through her innovative patent demonstrate her commitment to improving medication efficacy. Her work continues to influence the industry positively.